Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Phase II Study With the PDE4 Inhibitor Roflumilast in People Suffering From Long-term Cognitive Sequela After Stroke

NCT04854811 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT04854811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04854811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Phase II Study With the PDE4 Inhibitor Roflumilast in People Suffering From Long-term Cognitive Sequela After Stroke
Lead sponsor
Maastricht University
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2021
Completion date
December 1, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disorders, drug intervention, functional recovery, memory